NutriTRAILomics in prostate cancer: Time to have two strings to one's bow

Molecular Biology Reports

Volumn 39, Issue 4, 2012, Pages 4909-4914

  Farooqi, Ammad Ahmad ^a   Rana, Aamir ^b   Riaz, Asma M ^a   Khan, Ammara ^b   Ali, Muhammad ^a   Javed, Sara ^a   Mukhtar, Shahzeray ^a   Minhaj, Sehrish ^a   Rao, Javeria Rafique ^a   Rajpoot, Javairia ^a   Amber, Rafia ^a   Javed, Fiza Asif ^a   Waqar Un Nisa, ^a   Khanum, Reema ^a   Bhatti, Shahzad ^a  

^a UNIVERSITY OF LAHORE   (Pakistan)

^b NATIONAL UNIVERSITY OF SCIENCES AND TECHNOLOGY   (Pakistan)

Author keywords

EGCG; Prostate cancer; Resveratrol; TRAIL

Indexed keywords

CLUSTERIN; CURCUMIN; EPIGALLOCATECHIN GALLATE; JANUS KINASE; NUTRACEUTICAL; PROTEIN TYROSINE KINASE; RESVERATROL; STAT1 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 3; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

APOPTOSIS; CANCER CELL CULTURE; CANCER COMBINATION CHEMOTHERAPY; CANCER PREVENTION; DRUG EFFICACY; DRUG POTENTIATION; HUMAN; METABOLOMICS; MONOTHERAPY; NONHUMAN; NUTRIGENOMICS; PHYTONUTRIENT; PHYTOTHERAPY; PROSTATE CANCER; PROTEOMICS; REVIEW; BIOLOGICAL MODEL; DIET SUPPLEMENTATION; MALE; PROSTATE TUMOR;

DIETARY SUPPLEMENTS; HUMANS; MALE; MODELS, BIOLOGICAL; NUTRIGENOMICS; PROSTATIC NEOPLASMS; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 84863113670     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-011-1286-0     Document Type: Review

References (32)

1. Farooqi AA, Waseem S, Ashraf MS, Iqbal MJ, Bhatti S (2011) TRAIL and guardian angel of genome integrity: ATM boards TRAIL blazer. J Cancer Res Clin Oncol 137:1283-1287
2. Farooqi AA, Mansoor Q, Rana A, Mashhadi TM, Imran M, Naqi SA, Zia-ur-Rehman, Bhatti S (2011) SMURF and NEDD4 interference offers therapeutic potential in chaperoning genome integrity. J Exp Integr Med 1:43-50
3. Horndasch M, Culig Z (2011) SOCS-3 antagonizes pro-apoptotic effects of TRAIL and resveratrol in prostate cancer cells. Prostate 71(12):1357-1366. doi:10.1002/pros.21353
4. Sallman DA, Chen X, Zhong B, Gilvary DL, Zhou J, Wei S, Djeu JY (2007) Clusterin mediates TRAIL resistance in prostate tumor cells. Mol Cancer Ther 6:2938-2947
5. Ganapathy S, Chen Q, Singh KP, Shankar S, Srivastava RK (2010) Resveratrol enhances antitumor activity of TRAIL in prostate cancer xenografts through activation of FOXO transcription factor. PLoS One 5(12):e15627
6. Chen Q, Ganapathy S, Singh KP, Shankar S, Srivastava RK (2010) Resveratrol induces growth arrest and apoptosis through activation of FOXO transcription factors in prostate cancer cells. PLoS One 5(12):e15288
7. Gill C, Walsh SE, Morrissey C, Fitzpatrick JM, Watson RW (2007) Resveratrol sensitizes androgen independent prostate cancer cells to death-receptor mediated apoptosis through multiple mechanisms. Prostate 67:1641-1653
8. Shankar S, Chen Q, Siddiqui I, Sarva K, Srivastava RK (2007) Sensitization of TRAIL-resistant LNCaP cells by resveratrol (3,40,5 tri-hydroxystilbene): Molecular mechanisms and therapeutic potential. J Mol Signal 2:7
9. Andrzejewski T, Deeb D, Gao X, Danyluk A, Arbab AS, Dulchavsky SA, Gautam SC (2008) Therapeutic efficacy of curcumin/ TRAIL combination regimen for hormone-refractory prostate cancer. Oncol Res 17:257-267
10. Shankar S, Ganapathy S, Chen Q, Srivastava RK (2008) Curcumin sensitizes TRAIL-resistant xenografts: Molecular mechanisms of apoptosis, metastasis and angiogenesis. Mol Cancer 7:16
11. Deeb D, Jiang H, Gao X, Al-Holou S, Danyluk AL, Dulchavsky SA, Gautam SC (2007) Curcumin [1,7-bis(4-hydroxy-3-methoxyphenyl)-1-6-heptadine-3,5-dione; C21H20O6] sensitizes human prostate cancer cells to tumor necrosis factor-related apoptosisinducing ligand/Apo2L-induced apoptosis by suppressing nuclear factor-kappaB via inhibition of the prosurvival Akt signaling pathway. J Pharmacol Exp Ther 321:616-625
12. Srivastava RK, Chen Q, Siddiqui I, Sarva K, Shankar S (2007) Linkage of curcumin-induced cell cycle arrest and apoptosis by cyclin-dependent kinase inhibitor p21(/WAF1/CIP1). Cell Cycle 6:2953-2961
13. Shankar S, Chen Q, Sarva K, Siddiqui I, Srivastava RK (2007) Curcumin enhances the apoptosis-inducing potential of TRAIL in prostate cancer cells: Molecular mechanisms of apoptosis, migration and angiogenesis. J Mol Signal 2:10
14. Siddiqui IA, Malik A, Adhami VM, Asim M, Hafeez BB, Sarfaraz S, Mukhtar H (2008) Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis. Oncogene 27:2055-2063
15. Ahmad KA, Harris NH, Johnson AD, Lindvall HC, Wang G, Ahmed K (2007) Protein kinase CK2 modulates apoptosis induced by resveratrol and epigallocatechin-3-gallate in prostate cancer cells. Mol Cancer Ther 6:1006-1012
16. Sanna V, Pintus G, Roggio AM, Punzoni S, Posadino AM, Arca A, Marceddu S, Bandiera P, Uzzau S, Sechi M (2011) Targeted biocompatible nanoparticles for the delivery of (-)-epigallocatechin 3-gallate to prostate cancer cells. J Med Chem 54(5): 1321-1332
17. Rocha S, Generalov R, Pereira Mdo C, Peres I, Juzenas P, Coelho MA (2011) Epigallocatechin gallate-loaded polysaccharide nanoparticles for prostate cancer chemoprevention. Nanomedicine (Lond) 6:79-87
18. Seon MR, Lim SS, Choi HJ, Park SY, Cho HJ, Kim JK, Kim J, Kwon DY, Park JH (2010) Isoangustone A present in hexane/ ethanol extract of Glycyrrhiza uralensis induces apoptosis in DU145 human prostate cancer cells via the activation of DR4 and intrinsic apoptosis pathway. Mol Nutr Food Res 54:1329-1339
19. Szliszka E, Czuba ZP, Mazur B, Sedek L, Paradysz A, Krol W (2009) Chalcones enhance TRAIL-induced apoptosis in prostate cancer cells. Int J Mol Sci 11:1-13
20. Szliszka E, Czuba ZP, Mazur B, Paradysz A, Krol W (2010) Chalcones and dihydrochalcones augment TRAIL-mediated apoptosis in prostate cancer cells. Molecules 15:5336-5353
21. Szliszka E, Czuba ZP, Sedek L, Paradysz A, Król W (2011) Enhanced TRAIL-mediated apoptosis in prostate cancer cells by the bioactive compounds neobavaisoflavone and psoralidin isolated from Psoralea corylifolia. Pharmacol Rep 63:139-148
22. Tang Y, Li X, Liu Z, Simoneau AR, Xie J, Zi X, Flavokawain B (2010) A kava chalcone, induces apoptosis via up-regulation of death-receptor 5 and Bim expression in androgen receptor negative, hormonal refractory prostate cancer cell lines and reduces tumor growth. Int J Cancer 127:1758-1768
23. Szliszka E, Zydowicz G, Janoszka B, Dobosz C, Kowalczyk-Ziomek G, Krol W (2011) Ethanolic extract of Brazilian green propolis sensitizes prostate cancer cells to TRAIL-induced apoptosis. Int J Oncol 38:941-953
24. Sung B, Park B, Yadav VR, Aggarwal BB (2010) Celastrol, a triterpene, enhances TRAIL-induced apoptosis through the downregulation of cell survival proteins and up-regulation of death receptors. J Biol Chem 285:11498-11507
25. Yodkeeree S, Sung B, Limtrakul P, Aggarwal BB (2009) Zerumbone enhances TRAIL-induced apoptosis through the induction of death receptors in human colon cancer cells: Evidence for an essential role of reactive oxygen species. Cancer Res 69: 6581-6589
26. Lee DH, Rhee JG, Lee YJ (2009) Reactive oxygen species upregulate p53 and Puma; a possible mechanism for apoptosis during combined treatment with TRAIL and wogonin. Br J Pharmacol 157:1189-1202
27. Son YG, Kim EH, Kim JY, Kim SU, Kwon TK, Yoon AR, Yun CO, Choi KS (2007) Silibinin sensitizes human glioma cells to TRAIL-mediated apoptosis via DR5 up-regulation and downregulation of c-FLIP and survivin. Cancer Res 67:8274-8284
28. Deep G, Gangar SC, Oberlies NH, Kroll DJ, Agarwal R (2010) Isosilybin A induces apoptosis in human prostate cancer cells via targeting Akt, NF-jB, and androgen receptor signaling. Mol Carcinog 49:902-912
29. Farooqi AA, Fayyaz S, Mansoor Q, Ismail M, Bhatti S (2011) Towards TRAIL to silencing of SMURF and NEDD4: FLIP is flopped. J Exp Integr Med 1:111-116
30. Farooqi AA, Bhatti S, Rana A, Fayyaz S, Mansoor Q, Javed Z, Riaz AM, Nisar K, Ahsan QA, Dilawar BA, Asif H, Khanum R, Javeed MK (2011) Shattering the underpinnings of neoplastic architecture in LNCap: Synergistic potential of nutraceuticals in dampening PDGFR/EGFR signaling and cellular proliferation. J Exp Ther Oncol 9(3):201-206
31. Farooqi AA, Mansoor Q, Ismail M, Bhatti S (2010) Therapeutic effect of epigallocatechin-3-gallate (EGCG) and silibinin on ATM dynamics in prostate cancer cell line LNCaP. World J Oncol 1:242-246
32. Farooqi AA, Mukhtar S, Riaz AM, Waseem S, Minhaj S, Dilawar BA, Malik BA, Nawaz A, Bhatti S (2011) Wnt and SHH in prostate cancer: Trouble mongers occupy the TRAIL towards apoptosis. Cell Prolif 44(6):508-515. doi:10.1111/j.1365- 2184.2011. 00784.x